RecruitingNCT05189808

Radiofrequency Ablation for BIII Thyroid Nodules

Radiofrequency Ablation for Indeterminate Bethesda III Thyroid Nodules


Sponsor

Columbia University

Enrollment

50 participants

Start Date

Aug 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this observational chart review study is to evaluate the efficacy and safety of Radiofrequency Ablation (RFA) for treatment of indeterminate thyroid nodules before and after RFA procedure. This is a data collection study in which the investigators ask patients to give access to information generated before and after RFA treatment of their condition. The RFA procedure uses image guidance to place an electrode through the skin into the target area. In RFA, high-frequency electrical currents are passed through an electrode, creating a small region of heat to treat the lesion.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Indeterminate Bethesda III nodules that have been molecularly profiled benign with either Afirma Genomic Sequencing Classifier (GSC) or ThyroSeq v3 tests

Exclusion Criteria2

  • cardiac arrthymias
  • pregnancy

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURERadiofrequency Ablation

Ultrasound guided radiofrequency ablation (non-experimental)


Locations(1)

Columbia University

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05189808